Earnings Feed
Start Free
Home/Filings/4/0001209191-21-069032
4//SEC Filing

Hofmeister Robert 4

Accession 0001209191-21-069032

CIK 0001750019other
View on SEC.govCompany Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:30 PM ET

Size

6.0 KB

Accession

0001209191-21-069032

Insider Transaction Report

Form 4
Period: 2021-12-09
TCR2 THERAPEUTICS INC.TCRR
Hofmeister Robert
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-09+100,000→ 100,000 total
    Exercise: $5.21Exp: 2031-12-08→ Common Stock (100,000 underlying)
Holdings

  • Common Stock

    45,850
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.

Documents

1 file

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

→
Entity typeother

Related Parties

1
  • filerCIK 0001760102

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:30 PM ET
Size
6.0 KB
View on SEC.gov